PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.205
+0.005 (0.42%)
Jan 16, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 832.47 million as of January 16, 2026. Its market cap has decreased by -40.64% in one year.
Market Cap
832.47M
Enterprise Value
816.02M
Revenue
128.70M
Ranking
n/a
PE Ratio
63.76
Stock Price
1.21
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 832.47M, an increase of 2,415.98%. That is a compound annual growth rate of 12.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 832.47M | -2.03% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.55B |
| Pro Medicus | 21.90B |
| Cochlear | 17.28B |
| Sonic Healthcare | 11.38B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |